期刊文献+

氟尿嘧啶原料药的质量控制及稳定性研究 被引量:3

Study on quality control and stability of fluorouracil bulk drug
下载PDF
导出
摘要 目的建立抗肿瘤药氟尿嘧啶原料药的质量控制方法,并考察其稳定性。方法采用高效液相色谱法测定氟尿嘧啶原料药含量和有关物质,并对其进行稳定性考察。结果建立了氟尿嘧啶原料药的质量控制方法,包括性状、鉴别、干燥失重(≤0.3%)、炽灼残渣(≤0.1%)、重金属(≤0.002%)、有关物质(≤0.5%)和含量测定(98.0%~102.0%),样品检测结果在规定的限度内。对氟尿嘧啶样品进行了影响因素试验考察,在高温、高湿条件下无明显降解。在光照5、10d条件下含量均无明显变化,并分别在加速试验[(40±2)℃,相对湿度75%±5%]条件下进行了6个月和长期试验[(30±2)℃,相对湿度60%±5%]条件下进行了9个月的稳定性试验,稳定性考察期内各项指标未见明显变化。结论所建立的氟尿嘧啶原料药质量控制方法重复性好、专属性强,结果准确、可靠,耐用性检测结果在规定的限度内,氟尿嘧啶原料药稳定性良好。 Objective To establish the quality control method of antitumor drug fluorouracil bulk drug and to investigate its stability. Methods The content and related substances in fluorouracil bulk drug were determined by high performance liquid chromatography (HPLC) and its stability was investigated. Results The quality control method of fuorouracil bulk drug was estab- lished,including character,identification,drying loss ( ≤0.3% ) ,residue on ignition ( ≤0.1% ) ,heavy metals ( ≤0.002% ) ,related substances (≤0.5%) and content determination(98.0%-102.0%). The sample test results were all within the limits specified. Mean- while,the fuorouracil sample was performed the influencing factor test,the results showed that there was no obvious fluorouracil degradation under the condition of high temperature and high humidity,there were no obvious changes under the condition of 5,10 d illumination, the 6-month and 9-month stability tests were performed in the condition of the accelerated testing[(40±2)℃, relative humidity (RH)75%±5%] and the long-term testing[ (30±2)℃, RH 50%±5%] respectively, the various indicators had no obvious changes during the stability investigation period. Conclusion The established quality control method of fluorouracil bulk drug has good repeatability, strong specificity, and accurate and reliable results, the detection results of the durability test are within the lim- its specified, fluorouracil bulk drug has good stability.
作者 严宾 张伟男
出处 《现代医药卫生》 2015年第20期3070-3072,共3页 Journal of Modern Medicine & Health
关键词 抗肿瘤药 氟尿嘧啶 质量控制 参考标准 色谱法 高效液相 药物稳定性 Antineoplastic agents Fluorouracil Quality control Reference standards Chromatography,high pressure liquid Drug stability
  • 相关文献

参考文献10

  • 1Kugimiya N ,Nishimoto A,Hosoyama T,et al. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells[J]. J Cell Mol Med ,2015,19(7) :1569-1581.
  • 2Shakeel F, Haq N, A1-Dhfyan A, et al. Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil :a preliminary study[J]. Drug Deliv, 2015,22 (4) : 573-580.
  • 3Wu BB, Gong YP,Wu XH, et al. Fourier transform infrared spectroscopy for the distinction of MCF-7 ceils treated with different concentrations of 5-fluoruuracil[J]. J Transl Med ,2015,13 : 108.
  • 4Matsusaka S, Lenz HI. Pharmacogenomics of flnorouracil-basod chemo- therapy toxicity[J]. Expert Opin Drug Metal) Toxicol,2015,11 (5):811-821.
  • 5Kassab HI, Khalil YI. 5-Fluorouraeil mueoadhesive liquid suppository formulation and evaluation[J]. World J Pharm Res,2014,3 (9) : 119-135.
  • 6van Kuilenburg AB. Dihydmpyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil[J]. Eur J Cancer, 2004,40 (7) : 939-950.
  • 7Ragnhammar P, Blomgren H. How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer[J]. Med Oncol, 1995, 12 (3) : 187-201.
  • 8Sloan KB, Wasdo S. Designing for topcial delivery : prodrugs can make the difference [J]. Med IRes Rev ,2003,23(6) :763-793.
  • 9Smith NF, Figg WD, Sparreboom A. Recent advances in pharmacogenetic approaches to antieancer drug development [J].Drug Development Res, 2004,62:233-253.
  • 10《化学药物质量标准建立的规范化过程技术指导原则》课题研究组.化学药物质量标准建立的规范化过程技术指导原则[EB/0L].[2005-6-30].http://www.doe88.com/p-3347597235110.html.

同被引文献19

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部